Scarica l'app Stockscreener
1.285
3.62%
-0.055
Precedente Chiudi:
$1.34
Aprire:
$1.3
Volume 24 ore:
291.70K
Relative Volume:
0.06
Capitalizzazione di mercato:
$8.97M
Reddito:
$513.90K
Utile/perdita netta:
$-48.50M
Rapporto P/E:
-0.0459
EPS:
-28.0101
Flusso di cassa netto:
$-28.99M
1 W Prestazione:
-13.32%
1M Prestazione:
-47.50%
6M Prestazione:
-64.22%
1 anno Prestazione:
-87.42%
Intervallo 1D:
$1.26
$1.32
Intervallo di 1 settimana:
$1.28
$1.575
Portata 52W:
$1.26
$13.54
Co Diagnostics Inc Stock (CODX) Company Profile
Nome
Co Diagnostics Inc
Settore
Industria
Telefono
(801) 438-1036
Indirizzo
2401 S FOOTHILL DRIVE, SALT LAKE CITY
Compare CODX vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CODX
Co Diagnostics Inc
|
1.285 | 9.35M | 513.90K | -48.50M | -28.99M | -28.01 |
ABT
Abbott Laboratories
|
113.01 | 190.98B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
334.76 | 127.22B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
92.61 | 115.97B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
51.14 | 74.53B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
91.48 | 52.34B | 6.30B | 1.07B | 1.09B | 1.8406 |
Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-08-12 | Downgrade | Sidoti | Buy → Neutral |
| 2021-12-29 | Iniziato | Sidoti | Buy |
| 2021-03-29 | Downgrade | Maxim Group | Buy → Hold |
| 2020-05-20 | Aggiornamento | Maxim Group | Hold → Buy |
| 2020-05-18 | Reiterato | H.C. Wainwright | Buy |
| 2020-03-09 | Reiterato | H.C. Wainwright | Buy |
| 2020-03-03 | Downgrade | Maxim Group | Buy → Hold |
Mostra tutto
Co Diagnostics Inc Borsa (CODX) Ultime notizie
Co-Diagnostics Inc (CODX) Stock News Today - TradingKey
Co-Diagnostics seeks FDA clearance for new PCR Flu A/B & RSV test, prepping for U.S. launch. - Pluang
Co-Diagnostics joins Utah roundtable on AI and medical devices - Stock Titan
Maxim Group Upgrades Co-Diagnostics to Buy From Hold, $4 Price Target - marketscreener.com
CODX Stock Explodes Over 630% In Six Sessions – Retail Traders Bet The Rally Isn’t Over Yet - Stocktwits
Company-diagnostics Stock Price Forecast. Should You Buy CODX? - StockInvest.us
Armistice Capital discloses 9.99% Co-Diagnostics (CODX) holding via Master Fund - Stock Titan
Co-Diagnostics, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Co-diagnostics(CODX) Stock Options Chain | Quotes & News - Moomoo
CODX|Co-Diagnostics Inc|Price:1.460|Chg%:-0.020 - TradingKey
Co-Diagnostics (CODX) Earnings Call Q2 2026: FDA-Antrag schreitet voran, während Barmittel sinken - TradingKey
Co-Diagnostics (CODX) Q2 2026 Earnings Call: FDA Filing Advances as Cash Falls - TradingKey
Co-Diagnostics Inc (CODX) (Q2 2026) Earnings Call Highlights: FD - GuruFocus
Is Co-Diagnostics Inc (CODX) Undervalued Despite Q2 Earnings Mis - GuruFocus
Co-Diagnostics Q2 Results: Net loss narrows to $6.3 million - scanx.trade
Co-Diagnostics Reports Q2 2026 Results: Full Earnings Call Transcript - Benzinga
Earnings call transcript: Co-Diagnostics narrows loss in Q2 2026 but revenue stays thin - Investing.com
Co-Diagnostics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Co-Diagnostics (CODX) Stock Falls on Q2 2026 Earnings - Quiver Quantitative
Q2 2026 Co-Diagnostics Inc Earnings Call Transcript - GuruFocus
Co-Diagnostics Q2 2026 Earnings: Losses Narrow as Revenue Stays Near $0.17 Million - TradingKey
Co-Diagnostics (CODX) posts Q2 loss and flags going concern, raises new equity - Stock Titan
Co-Diagnostics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Co-Diagnostics Q2 revenue rises slightly amid international expansion - TradingView
Co-Diagnostics, Inc. (CODX) Latest Stock News & Headlines - Yahoo Finance
Press Release: Co-Diagnostics Reports Second Quarter 2026 Financial Results - 富途牛牛
Co-Diagnostics Inc (CODX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CODX Q2'26 Earnings: EPS estimate is (3.00) USD - TradingView
Co-Diagnostics Inc expected to post a loss of $3.00 a shareEarnings Preview - TradingView
Why Did CODX Stock Nearly Double In Value Today? - Stocktwits
Co-Diagnostics (NASDAQ: CODX) sees Jane Street disclose 1.7% equity stake - Stock Titan
CODX Stock Price, Quote & Chart - ChartMill
Co-Diagnostics submits FDA 510(k) for respiratory test By Investing.com - Investing.com South Africa
CODX Looks 28.1% Undervalued on GF Value™ Amid Challenging Finan - GuruFocus
Co-Diagnostics submits FDA application for dece... - Pluang
Co-Diagnostics submits FDA 510(k) for respiratory test - Investing.com
Co-Diagnostics Submits FDA 510(k) Premarket Notification for Upper Respiratory Point-of-Care Test - PR Newswire
CODX Q2'26 Earnings: revenue estimate is 132.58K USD - TradingView
Weekly Recap: Co-Diagnostics, Inc. Q2 results date and Bundibugyo test - TradingView
Co-Diagnostics Raises Capital Through Warrant Inducement Ahead of FDA Review - The Clinical Trial Vanguard
Why Is Co-Diagnostics (NASDAQ:CODX) In Focus After Its Latest Molecular Diagnostics Update? - Kalkine Media
Co-Diagnostics holders exercise 1,702,362 warrants at USD 1.57 per share in inducement deal - Bitget
Co-Diagnostics Plans Aug. 13 Webcast on Second-Quarter Results - Stock Titan
Co-Diagnostics Inc (CODX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
EXCLUSIVE: Co-Diagnostics Announces Successful Proof of Concept for Extraction-Free Ebola Test - Yahoo Finance
CODX Looks 3.8% Undervalued on GF Value™ as Market Prices in Cha - GuruFocus
Co-Diagnostics Joint Venture CoSara provides Ebola Test Kits for analytical studies - BioSpectrum Asia
Co-Diagnostics Joint Venture CoSara Provides Ebola Test Kits for Analytical Studies - PR Newswire
Co-Diagnostics, Inc. Announces Amendment to Equity Distribution Agreement with Maxim Group LLC – July 2026 SEC Filing Update – Minichart - Minichart
Co-DiagnosticsAmends Equity Distribution Agreement With Maxim Group For Common Stock SaleSEC Filing - TradingView
Co-Diagnostics Updates ATM With Maxim, Extends Share Standstill to Aug. 14, 2026 - TradingView
Co Diagnostics Inc Azioni (CODX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):